<DOC>
	<DOCNO>NCT01431053</DOCNO>
	<brief_summary>This phase II study ass efficacy/safety Exemestane without Aspirin adjuvant treatment postmenopausal breast cancer patient .</brief_summary>
	<brief_title>Study Aspirin Exemestane Adjuvant Treatment Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Exemestane</mesh_term>
	<criteria>Breast cancer surgery postmenopausal contraindication aspirin</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>exemestane</keyword>
	<keyword>aspirin</keyword>
	<keyword>quality life</keyword>
</DOC>